Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: January 2012
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Making the Move to First-to-File" on Wednesday, January 18, 2012 beginning at 2:00 pm (ET). A panel consisting of Ned Israelsen of Knobble Martens Olson & Bear, LLP; Stuart Watt of Amgen Inc.; and Harold Wegner of Foley & Lardner, LLP will: •…
-
Statistics Illustrate Costs of Generic Drugs to Innovation By Kevin E. Noonan — The question of whether the Hatch-Waxman generic drug regime is a net positive for innovation and drug development has been the subject of recent study, particularly in view of the costs attendant on litigation between branded ("innovator") drug makers and their generic…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office published four Federal Register notices as part of its efforts to implement the Leahy-Smith America Invents Act. Yesterday, we discussed the Office's notice regarding implementation of miscellaneous post patent provisions in the AIA (see "USPTO Proposes Rules Changes for Implementing AIA Provisions —…
-
By Donald Zuhn — Last fall, the U.S. Patent and Trademark Office announced that it would be releasing a number of a Federal Register notices in January as part of the Office's efforts to implement the Leahy-Smith America Invents Act (see "USPTO News Briefs"). On Friday, the Office issued a press release noting that four…
-
By Kevin E. Noonan — The effects of the Supreme Court's decision in KSR Int'l Co. v. Teleflex Inc. continue to ripple unpredictably through the Federal Circuit's jurisprudence, promoting inconsistencies in obviousness determinations by the Court that seem contrary to its mandate to harmonize U.S. patent law. The most recent illustration of this effect is…
-
By Donald Zuhn — On December 28, the U.S. Patent and Trademark Office issued a notice of proposed rule making regarding certain patent term adjustment (PTA) provisions in the Federal Register (76 Fed. Reg. 81432). In particular, the Office has proposed that the period of adjustment for applications involved in appellate review begin when jurisdiction…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Takeda Pharmaceutical Co. et al. v. Mylan, Inc. et al.1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and…
-
January 11, 2012 – Biotechnology European Patent Case Law (D Young & Co.) – 7:00 – 7:45 am and 12:00 – 12:45 pm (EST) January 20, 2012 – Prosecution Strategies: Tackling USPTO Obviousness Rejections (American Bar Association) – 1:00 – 2:30 pm (Eastern) January 25-26, 2012 – Biosimilars Forum 2012 (C5) – London, UK January…
-
D Young & Co. will be offering a live webinar on "Biotechnology European Patent Case Law" on January 11, 2012. The 45-minute webinar will be offered at two times: 7:00 am (EST) and 12:00 pm (EST). Robert Dempster and Simon O'Brien will provide an essential update and live Q&A on European biotechnology case law. While…
-
The American Bar Association (ABA) Section of Intellectual Property Law, Young Lawyers Division, ABA-IPL Young Lawyers Action Group, and Center for Continuing Legal Education will be offering a live webinar entitled "Prosecution Strategies: Tackling USPTO Obviousness Rejections" on January 20, 2012 from 1:00 – 2:30 pm (Eastern). Dr. Janet S. Hendrickson (moderator) of Senniger Powers…
Patent Docs 